ZhuZhou QianJin Pharmaceutical Co Ltd - Asset Resilience Ratio
ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has an Asset Resilience Ratio of 0.03% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ZhuZhou QianJin Pharmaceutical Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2001–2025)
This chart shows how ZhuZhou QianJin Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see ZhuZhou QianJin Pharmaceutical Co Ltd asset portfolio.
Liquid Assets Composition Over Time
This chart breaks down ZhuZhou QianJin Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore how much of ZhuZhou QianJin Pharmaceutical Co Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.55 Million | 0.03% |
| Total Liquid Assets | CN¥1.55 Million | 0.03% |
Asset Resilience Insights
- Limited Liquidity: ZhuZhou QianJin Pharmaceutical Co Ltd maintains only 0.03% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
ZhuZhou QianJin Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare ZhuZhou QianJin Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM |
Drug Manufacturers - Specialty & Generic | 2.79% |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Beijing Tongrentang Co Ltd
SHG:600085 |
Drug Manufacturers - Specialty & Generic | 2.51% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
Drug Manufacturers - Specialty & Generic | 20.44% |
|
Harbin Pharmaceutical Group Co Ltd
SHG:600664 |
Drug Manufacturers - Specialty & Generic | 0.97% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
Annual Asset Resilience Ratio for ZhuZhou QianJin Pharmaceutical Co Ltd (2001–2025)
The table below shows the annual Asset Resilience Ratio data for ZhuZhou QianJin Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.04% | CN¥1.94 Million ≈ $283.18K |
CN¥4.96 Billion ≈ $726.34 Million |
-0.07pp |
| 2024-12-31 | 0.10% | CN¥4.76 Million ≈ $697.02K |
CN¥4.56 Billion ≈ $666.73 Million |
-10.53pp |
| 2022-12-31 | 10.64% | CN¥491.74 Million ≈ $71.96 Million |
CN¥4.62 Billion ≈ $676.34 Million |
-7.51pp |
| 2021-12-31 | 18.15% | CN¥736.84 Million ≈ $107.82 Million |
CN¥4.06 Billion ≈ $594.14 Million |
+2.72pp |
| 2020-12-31 | 15.42% | CN¥652.25 Million ≈ $95.44 Million |
CN¥4.23 Billion ≈ $618.79 Million |
+12.28pp |
| 2018-12-31 | 3.14% | CN¥109.05 Million ≈ $15.96 Million |
CN¥3.47 Billion ≈ $508.13 Million |
-2.40pp |
| 2017-12-31 | 5.54% | CN¥182.19 Million ≈ $26.66 Million |
CN¥3.29 Billion ≈ $480.97 Million |
+5.29pp |
| 2016-12-31 | 0.26% | CN¥7.76 Million ≈ $1.14 Million |
CN¥3.03 Billion ≈ $443.69 Million |
-0.88pp |
| 2015-12-31 | 1.13% | CN¥31.09 Million ≈ $4.55 Million |
CN¥2.74 Billion ≈ $401.42 Million |
-1.99pp |
| 2014-12-31 | 3.12% | CN¥69.56 Million ≈ $10.18 Million |
CN¥2.23 Billion ≈ $326.16 Million |
+1.95pp |
| 2013-12-31 | 1.17% | CN¥22.12 Million ≈ $3.24 Million |
CN¥1.89 Billion ≈ $276.32 Million |
-4.45pp |
| 2012-12-31 | 5.62% | CN¥92.52 Million ≈ $13.54 Million |
CN¥1.65 Billion ≈ $240.75 Million |
-2.06pp |
| 2011-12-31 | 7.69% | CN¥98.53 Million ≈ $14.42 Million |
CN¥1.28 Billion ≈ $187.55 Million |
+2.35pp |
| 2010-12-31 | 5.34% | CN¥60.27 Million ≈ $8.82 Million |
CN¥1.13 Billion ≈ $165.13 Million |
-12.99pp |
| 2009-12-31 | 18.33% | CN¥231.98 Million ≈ $33.95 Million |
CN¥1.27 Billion ≈ $185.22 Million |
+18.31pp |
| 2008-12-31 | 0.02% | CN¥176.50K ≈ $25.83K |
CN¥1.06 Billion ≈ $155.02 Million |
-11.96pp |
| 2007-12-31 | 11.98% | CN¥130.01 Million ≈ $19.02 Million |
CN¥1.09 Billion ≈ $158.81 Million |
+7.76pp |
| 2006-12-31 | 4.22% | CN¥34.99 Million ≈ $5.12 Million |
CN¥828.73 Million ≈ $121.27 Million |
+3.47pp |
| 2005-12-31 | 0.75% | CN¥6.03 Million ≈ $881.81K |
CN¥798.23 Million ≈ $116.81 Million |
-0.01pp |
| 2004-12-31 | 0.77% | CN¥6.09 Million ≈ $890.72K |
CN¥792.53 Million ≈ $115.97 Million |
+0.72pp |
| 2001-12-31 | 0.05% | CN¥172.00K ≈ $25.17K |
CN¥332.78 Million ≈ $48.70 Million |
-- |
About ZhuZhou QianJin Pharmaceutical Co Ltd
ZhuZhou QianJin Pharmaceutical Co.,Ltd researches, develops, produces, and sells traditional Chinese medicines, chemicals and API, and TCM derivatives in China. The company offers TCM products, chemical medicine, derivative products, and hygienic products, including gynaecological and baby nursing, and maternity pad/ maternity package. ZhuZhou QianJin Pharmaceutical Co.,Ltd was founded in 1966 an… Read more